MR-Guided Cryoablation of Prostate Bed Recurrences

Prostate Tumors Clinical Trial

Official title:

Technical Success, Safety, and Short and Long-term Efficacy for MR-Guided Cryoablation of Prostate Bed Recurrences

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01727284
• Other study ID #: 12-002245
• Status: Recruiting
• Phase: N/A
• Start date: December 12, 2012
• Est. completion date: October 2024

Study information

• Verified date: January 2024
• Source: Mayo Clinic
• Contact: Deb Berg
• Phone: 507-255-8454
• Email: RSTInterventionalOncology[@]mayo.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: October 2024
• Est. primary completion date: October 2024
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 30 Years to 100 Years

Eligibility

Inclusion Criteria:

• Patients with "biopsy proven" soft tissue tumor recurrences of prostate fossa

• Surgery is not a desirable alternative therapy at the time of enrollment

• Radiation therapy has failed or not indicated or can be safely postponed

• Tumor size is < 5 cm at its largest diameter

• Tumor does not encompass the rectal wall or external urethral sphincter

• Patient is able to undergo MRI

Exclusion Criteria:

• N/A

Related Conditions & MeSH terms

• Prostate Tumors
• Prostatic Neoplasms
• Recurrence

Intervention

Procedure:
• MR-guided cryoablation

Locations

Country	Name	City	State
United States	Mayo Clinic in Rochester	Rochester	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evaluation of target lesion at 3-6, 12, 24, and 36 month imaging follow-up		3 years

External Links

•   Mayo Clinic Clinical Trials